133 related articles for article (PubMed ID: 14701826)
21. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
Morris L; Allen KE; La Thangue NB
Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
[TBL] [Abstract][Full Text] [Related]
22. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression.
Hall C; Nelson DM; Ye X; Baker K; DeCaprio JA; Seeholzer S; Lipinski M; Adams PD
Mol Cell Biol; 2001 Mar; 21(5):1854-65. PubMed ID: 11238922
[TBL] [Abstract][Full Text] [Related]
23. Phosphorylation independent activation of human cyclin-dependent kinase 2 by cyclin A in vitro.
Connell-Crowley L; Solomon MJ; Wei N; Harper JW
Mol Biol Cell; 1993 Jan; 4(1):79-92. PubMed ID: 8443411
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
25. The cyclin E/Cdk2 substrate p220(NPAT) is required for S-phase entry, histone gene expression, and Cajal body maintenance in human somatic cells.
Ye X; Wei Y; Nalepa G; Harper JW
Mol Cell Biol; 2003 Dec; 23(23):8586-600. PubMed ID: 14612403
[TBL] [Abstract][Full Text] [Related]
26. Cyclin E deregulation impairs mitotic progression through premature activation of Cdc25C.
Bagheri-Yarmand R; Nanos-Webb A; Biernacka A; Bui T; Keyomarsi K
Cancer Res; 2010 Jun; 70(12):5085-95. PubMed ID: 20530684
[TBL] [Abstract][Full Text] [Related]
27. CDK2 and cyclin E knockout mice: lessons from breast cancer.
Lents NH; Baldassare JJ
Trends Endocrinol Metab; 2004; 15(1):1-3. PubMed ID: 14693416
[TBL] [Abstract][Full Text] [Related]
28. Doenjang hexane fraction-induced G1 arrest is associated with the inhibition of pRB phosphorylation and induction of Cdk inhibitor p21 in human breast carcinoma MCF-7 cells.
Choi YH; Choi BT; Lee WH; Rhee SH; Park KY
Oncol Rep; 2001; 8(5):1091-6. PubMed ID: 11496322
[TBL] [Abstract][Full Text] [Related]
29. The oncogenic activity of cyclin E is not confined to Cdk2 activation alone but relies on several other, distinct functions of the protein.
Geisen C; Moroy T
J Biol Chem; 2002 Oct; 277(42):39909-18. PubMed ID: 12149264
[TBL] [Abstract][Full Text] [Related]
30. Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogens in T-47D breast cancer cells.
Hui R; Finney GL; Carroll JS; Lee CS; Musgrove EA; Sutherland RL
Cancer Res; 2002 Dec; 62(23):6916-23. PubMed ID: 12460907
[TBL] [Abstract][Full Text] [Related]
31. Helicobacter pylori releases a factor(s) inhibiting cell cycle progression of human gastric cell lines by affecting cyclin E/cdk2 kinase activity and Rb protein phosphorylation through enhanced p27(KIP1) protein expression.
Sommi P; Savio M; Stivala LA; Scotti C; Mignosi P; Prosperi E; Vannini V; Solcia E
Exp Cell Res; 2002 Nov; 281(1):128-39. PubMed ID: 12441136
[TBL] [Abstract][Full Text] [Related]
32. Endogenous basic fibroblast growth factor is essential for cyclin E-CDK2 activity in multiple external cytokine-induced proliferation of AIDS-associated Kaposi's sarcoma cells: dual control of AIDS-associated Kaposi's sarcoma cell growth and cyclin E-CDK2 activity by endogenous and external signals.
Murakami-Mori K; Mori S; Nakamura S
J Immunol; 1998 Aug; 161(4):1694-704. PubMed ID: 9712033
[TBL] [Abstract][Full Text] [Related]
33. Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells.
Oh M; Choi YH; Choi S; Chung H; Kim K; Kim SI; Kim DK; Kim ND
Int J Oncol; 1999 May; 14(5):869-75. PubMed ID: 10200336
[TBL] [Abstract][Full Text] [Related]
34. Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells.
Sweeney KJ; Sarcevic B; Sutherland RL; Musgrove EA
Oncogene; 1997 Mar; 14(11):1329-40. PubMed ID: 9178893
[TBL] [Abstract][Full Text] [Related]
35. A centrosomal localization signal in cyclin E required for Cdk2-independent S phase entry.
Matsumoto Y; Maller JL
Science; 2004 Oct; 306(5697):885-8. PubMed ID: 15514162
[TBL] [Abstract][Full Text] [Related]
36. Phosphorylation of the myristoylated protein kinase C substrate MARCKS by the cyclin E-cyclin-dependent kinase 2 complex in vitro.
Manenti S; Yamauchi E; Sorokine O; Knibiehler M; Van Dorsselaer A; Taniguchi H; Ducommun B; Darbon JM
Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):775-82. PubMed ID: 10359664
[TBL] [Abstract][Full Text] [Related]
37. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
[TBL] [Abstract][Full Text] [Related]
38. Lower molecular weight forms of cyclin E--super activators of the cell cycle?
Stighall M; Berglund P; Landberg G
Cell Cycle; 2003; 2(5):458-60. PubMed ID: 12963844
[No Abstract] [Full Text] [Related]
39. Phosphorylation of Sp1 by cyclin-dependent kinase 2 modulates the role of Sp1 in CTP:phosphocholine cytidylyltransferase alpha regulation during the S phase of the cell cycle.
Banchio C; Schang LM; Vance DE
J Biol Chem; 2004 Sep; 279(38):40220-6. PubMed ID: 15247247
[TBL] [Abstract][Full Text] [Related]
40. Cyclin E-CDK2 is a regulator of p27Kip1.
Sheaff RJ; Groudine M; Gordon M; Roberts JM; Clurman BE
Genes Dev; 1997 Jun; 11(11):1464-78. PubMed ID: 9192873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
